Showing all 2 results
Procyclidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Procyclidine HCl BP/Ph.Eur. 5 mg Global Clinical Standard: Base therapeutic unit for the rapid reversal of EPS and parkinsonian rigidity. Excipients Lactose Monohydrate / Sodium Starch Glycolate / Povidone / Magnesium Stearate Diluent / Superdisintegrant / Binder / Lubricant (Engineered for rapid gastric dissolution and ultra-fast crossing of the blood-brain barrier) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-volume daily dispensing in acute psychiatric and neurology wards).
Rasagiline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly sensitive mesylate salt.
Active Ingredient Strength Primary Clinical Function Rasagiline Mesylate INN/Ph.Eur. 0.5 mg (Base Equivalent) Adjunct Standard: Initiating dose when used in combination with Levodopa. Rasagiline Mesylate INN/Ph.Eur. 1 mg (Base Equivalent) Global Clinical Standard: Maximum daily dose for monotherapy or advanced adjunct therapy. Excipients Mannitol / Maize Starch / Pregelatinized Starch / Colloidal Silicon Dioxide / Stearic Acid Diluent / Binder / Superdisintegrant / Glidant (Engineered for immediate gastric dissolution and rapid crossing of the blood-brain barrier) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict high-compliance 30-day chronic neurology dispensing regimens).
